Four Decades of Fermentation: Angel Yeast’s Global Evolution

Since its founding, Angel Yeast has transformed home baking and industrial fermentation through massive production scale. The company now pivots toward advanced biotechnology, specifically focusing on yeast extracts that balance flavor profiles and the high-protein Angeopro line, which contains over 80% protein. According to Chairman Xiong Tao, this ingredient is transitioning from traditional baking and dairy sectors into high-growth areas like sports nutrition and medical foods.

Sustainability remains central to the company’s current operations. In 2025, Angel Yeast achieved an EcoVadis Silver rating, a milestone driven by a circular production model that repurposes agricultural byproducts and integrates solar and biomass energy. This environmental commitment is paired with aggressive geographic expansion. To sharpen its competitive edge, the firm has opened an R&D center in Belgium and is constructing a manufacturing facility in Indonesia. These moves align with a broader philosophy of localized supply chains, designed to reduce carbon footprints while tailoring products to regional consumer preferences.

Looking ahead, innovation serves as the primary engine for the company’s trajectory. By strengthening its global R&D network and investing in biopharmaceutical culture media, Angel Yeast aims to maintain its dominance in a shifting market. Xiong Tao emphasizes that the company’s long-term viability depends on its ability to retain specialized talent capable of navigating increasingly complex global trade environments.